Triage^® TOX Drug Screen

The Future of Point-of-Care Testing

The Value of Point-of-Care Drug Testing
Nearly every day patients are treated in emergency departments (ED) across the country for complications due to drug overdose. Attempting to identify the cause of the symptoms as drug-related and non-drug-related can cause considerable stress for ED physicians.

Rapid point-of-care drug testing with the Triage TOX Drug Screen makes sense to the ED:

• Improves patient care, and/or
• Reduces the expenses associated with additional diagnostic testing or unnecessary admissions

According to the National Academy of Clinical Biochemistry (NACB), Laboratory Medicine Practice Guidelines (LMPG), stat toxicology assays required to support an ED should have a turnaround time of one hour or less. The Triage TOX Drug Screen provides rapid results at the point-of-care in approximately 15 minutes.

A Breakthrough in Point-of-Care Drug Testing

Biosite Introduced the Triage Drugs of Abuse Panel in 1992
Introduced in 1992, the Triage Drugs of Abuse Panel was Biosite’s first rapid diagnostic test. Biosite subsequently introduced the first urine tricyclic antidepressants (TCA) application with the launch of Triage Plus TCA. Biosite’s Triage Drugs of Abuse Panels are used in more than 2,300 hospitals nationwide. That’s nearly 50 percent of all U.S. hospitals.

Please click here for more information regarding Triage Drugs of Abuse Panel